Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer

International Review of Cell and Molecular Biology

Volumn 324, Issue , 2016, Pages 229-254

  Alahari, S V ^a,b   Eastlack, S C ^c   Alahari, S K ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HOTAIR; Long noncoding RNA; MALAT1; Neoplasia; PCAT1; Prostate Cancer; XIST

Indexed keywords

BRAF ACTIVATED NONCODING RNA; COLON CANCER ASSOCIATED TRANSCRIPT 2; DOWNREGULATED RNA IN CANCER; GROWTH ARREST SPECIFIC TRANSCRIPT 5; HEPATOCELLULAR CARCINOMA UPREGULATED LONG NONCODING RNA; HOX TRANSCRIPT ANTISENSE RNA; LONG INTERGENIC NONCODING RNA 963; LONG UNTRANSLATED RNA; MATERNALLY EXPRESSED GENE 3; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; PROSTATE CANCER ASSOCIATED TRANSCRIPT 1; PROSTATE CANCER ASSOCIATED TRANSCRIPT 29; PROSTATE CANCER ASSOCIATED TRANSCRIPT 5; PROSTATE CANCER GENE EXPRESSION MARKER 1; RNA H19; RNA NEAT1; RNA PVT1; SECOND CHROMOSOME LOCUS ASSOCIATED WITH PROSTATE 1; UNCLASSIFIED DRUG; X INACTIVATED SPECIFIC TRANSCRIPT;

HUMAN; NONHUMAN; PROSTATE CANCER; ANIMAL; BIOLOGICAL MODEL; GENETICS; MALE; METABOLISM; PROSTATE TUMOR;

ANIMALS; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RNA, LONG NONCODING;

EID: 84959419908     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2016.01.004     Document Type: Chapter

References (113)

1. Anwar S.L., Krech T., Hasemeier B., Schipper E., Schweitzer N., Vogel A., Kreipe H., Lehmann U. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS ONE 2012, 7:e49462.
2. Arita T., Ichikawa D., Konishi H., Komatsu S., Shiozaki A., Shoda K., Kawaguchi T., Hirajima S., Nagata H., Kubota T., Fujiwara H., Okamoto K., Otsuji E. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013, 33:3185-3193.
3. Asselin-Labat M.L., Sutherland K.D., Vaillant F., Gyorki D.E., Wu D., Holroyd S., Breslin K., Ward T., Shi W., Bath M.L., Deb S., Fox S.B., Smyth G.K., Lindeman G.J., Visvader J.E. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol. Cell Biol. 2011, 31:4609-4622.
4. Barsotti A.M., Beckerman R., Laptenko O., Huppi K., Caplen N.J., Prives C. p53-Dependent induction of PVT1 and miR-1204. J. Biol. Chem. 2011, 287:2509-2519.
5. Barsyte-Lovejoy D., Lau S.K., Boutros P.C., Khosravi F., Jurisica I., Andrulis I.L., Tsao M.S., Penn L.Z. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006, 66:5330-5337.
6. Bartolomei M.S., Zemel S., Tilghman S.M. Parental imprinting of the mouse H19 gene. Nature 1991, 351:153-155.
7. Benetatos L., Hatzimichael E., Dasoula A., Dranitsaris G., Tsiara S., Syrrou M., Georgiou I., Bourantas K.L. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk. Res. 2010, 34:148-153.
8. Blyth K., Cameron E.R., Neil J.C. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer 2005, 5:376-387.
9. Boa S., Coert C., Patterton H.G. Saccharomyces cerevisiae Set1p is a methyltransferase specific for lysine 4 of histone H3 and is required for efficient gene expression. Yeast 2003, 20:827-835.
10. Braconi C., Kogure T., Valeri N., Huang N., Nuovo G., Costinean S., Negrini M., Miotto E., Croce C.M., Patel T. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011, 30:4750-4756.
11. Brooksbank C., Bergman M.T., Apweiler R., Birney E., Thornton J. The European Bioinformatics Institute's data resources 2014. Nucleic Acids Res. 2013, 42:D18-D25.
12. Carrozza M.J., Li B., Florens L., Suganuma T., Swanson S.K., Lee K.K., Shia W.J., Anderson S., Yates J., Washburn M.P., Workman J.L. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 2005, 123:581-592.
13. Chakravarty D., Sboner A., Nair S.S., Giannopoulou E., Li R., Hennig S., Mosquera J.M., Pauwels J., Park K., Kossai M., MacDonald T.Y., Fontugne J., Erho N., Vergara I.A., Ghadessi M., Davicioni E., Jenkins R.B., Palanisamy N., Chen Z., Nakagawa S., Hirose T., Bander N.H., Beltran H., Fox A.H., Elemento O., Rubin M.A. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat. Commun. 2014, 5:5383.
14. Chapman M.H., Tidswell R., Dooley J.S., Sandanayake N.S., Cerec V., Deheragoda M., Lee A.J., Swanton C., Andreola F., Pereira S.P. Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma. J. Hepatol. 2011, 56:877-885.
15. Chen L.F. Tumor suppressor function of RUNX3 in breast cancer. J. Cell. Biochem. 2012, 113:1470-1477.
16. Chimge N.O., Frenkel B. The RUNX family in breast cancer: relationships with estrogen signaling. Oncogene 2012, 32:2121-2130.
17. Clemson C.M., Hutchinson J.N., Sara S.A., Ensminger A.W., Fox A.H., Chess A., Lawrence J.B. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell 2009, 33:717-726.
18. Du Y., Kong G., You X., Zhang S., Zhang T., Gao Y., Ye L., Zhang X. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J. Biol. Chem. 2012, 287:26302-26311.
19. Endo H., Shiroki T., Nakagawa T., Yokoyama M., Tamai K., Yamanami H., Fujiya T., Sato I., Yamaguchi K., Tanaka N., Iijima K., Shimosegawa T., Sugamura K., Satoh K. Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS ONE 2013, 8:e77070.
20. Flockhart R.J., Webster D.E., Qu K., Mascarenhas N., Kovalski J., Kretz M., Khavari P.A. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012, 22:1006-1014.
21. Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene 2003, 22:9030-9040.
22. Gabory A., Jammes H., Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010, 32:473-480.
23. Ganesan S., Silver D.P., Greenberg R.A., Avni D., Drapkin R., Miron A., Mok S.C., Randrianarison V., Brodie S., Salstrom J., Rasmussen T.P., Klimke A., Marrese C., Marahrens Y., Deng C.X., Feunteun J., Livingston D.M. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 2002, 111:393-405.
24. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 2011, 10:38.
25. Gibb E.A., Vucic E.A., Enfield K.S., Stewart G.L., Lonergan K.M., Kennett J.Y., Becker-Santos D.D., MacAulay C.E., Lam S., Brown C.J., Lam W.L. Human cancer long non-coding RNA transcriptomes. PLoS ONE 2011, 6:e25915.
26. Ginger M.R., Shore A.N., Contreras A., Rijnkels M., Miller J., Gonzalez-Rimbau M.F., Rosen J.M. A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc. Natl. Acad. Sci. USA 2006, 103:5781-5786.
27. Grasso C.S., Wu Y.M., Robinson D.R., Cao X., Dhanasekaran S.M., Khan A.P., Quist M.J., Jing X., Lonigro R.J., Brenner J.C., Asangani I.A., Ateeq B., Chun S.Y., Siddiqui J., Sam L., Anstett M., Mehra R., Prensner J.R., Palanisamy N., Ryslik G.A., Vandin F., Raphael B.J., Kunju L.P., Rhodes D.R., Pienta K.J., Chinnaiyan A.M., Tomlins S.A. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012, 487:239-243.
28. Guan Y., Kuo W.L., Stilwell J.L., Takano H., Lapuk A.V., Fridlyand J., Mao J.H., Yu M., Miller M.A., Santos J.L., Kalloger S.E., Carlson J.W., Ginzinger D.G., Celniker S.E., Mills G.B., Huntsman D.G., Gray J.W. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin. Cancer Res. 2007, 13:5745-5755.
29. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012, 9:703-719.
30. Gutschner T., Hammerle M., Eissmann M., Hsu J., Kim Y., Hung G., Revenko A., Arun G., Stentrup M., Gross M., Zornig M., MacLeod A.R., Spector D.L., Diederichs S. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2012, 73:1180-1189.
31. Haas G.P., Delongchamps N., Brawley O.W., Wang C.Y., de la Roza G. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can. J. Urol. 2008, 15:3866-3871.
32. Hajjari M., Behmanesh M., Sadeghizadeh M., Zeinoddini M. Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med. Oncol. 2013, 30:670.
33. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1993, 365:764-767.
34. Haverty P.M., Hon L.S., Kaminker J.S., Chant J., Zhang Z. High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors. BMC Med. Genomics 2009, 2:21.
35. Holzbeierlein J., Lal P., LaTulippe E., Smith A., Satagopan J., Zhang L., Ryan C., Smith S., Scher H., Scardino P., Reuter V., Gerald W.L. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am. J. Pathol. 2004, 164:217-227.
36. Houseley J., Rubbi L., Grunstein M., Tollervey D., Vogelauer M. A ncRNA modulates histone modification and mRNA induction in the yeast GAL gene cluster. Mol. Cell. 2008, 32:685-695.
37. Huppi K., Volfovsky N., Runfola T., Jones T.L., Mackiewicz M., Martin S.E., Mushinski J.F., Stephens R., Caplen N.J. The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol. Cancer Res. 2008, 6:212-221.
38. Janes K.A. RUNX1 and its understudied role in breast cancer. Cell Cycle 2011, 10:3461-3465.
39. Ji P., Diederichs S., Wang W., Boing S., Metzger R., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E., Thomas M., Berdel W.E., Serve H., Muller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
40. Johnson R., Teh C.H., Jia H., Vanisri R.R., Pandey T., Lu Z.H., Buckley N.J., Stanton L.W., Lipovich L. Regulation of neural macroRNAs by the transcriptional repressor REST. RNA 2009, 15:85-96.
41. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., Stadler P.F., Hertel J., Hackermuller J., Hofacker I.L., Bell I., Cheung E., Drenkow J., Dumais E., Patel S., Helt G., Ganesh M., Ghosh S., Piccolboni A., Sementchenko V., Tammana H., Gingeras T.R. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
42. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Rivea Morales D., Thomas K., Presser A., Bernstein B.E., van Oudenaarden A., Regev A., Lander E.S., Rinn J.L. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. USA 2009, 106:11667-11672.
43. Kim K.S., Lee Y.I. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett. 1997, 119:143-148.
44. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., Miyano S., Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
45. Kotake Y., Nakagawa T., Kitagawa K., Suzuki S., Liu N., Kitagawa M., Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011, 30:1956-1962.
46. Kung J.T., Colognori D., Lee J.T. Long noncoding RNAs: past, present, and future. Genetics 2013, 193:651-669.
47. Lee J.T. Epigenetic regulation by long noncoding RNAs. Science 2012, 338:1435-1439.
48. Lee M.P., DeBaun M.R., Mitsuya K., Galonek H.L., Brandenburg S., Oshimura M., Feinberg A.P. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc. Natl. Acad. Sci. USA 1999, 96:5203-5208.
49. Li T., Hu J.F., Qiu X., Ling J., Chen H., Wang S., Hou A., Vu T.H., Hoffman A.R. CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol. Cell Biol. 2008, 28:6473-6482.
50. Liang Y., Liu J., Feng Z. The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci. 2013, 3:9.
51. Lin R., Maeda S., Liu C., Karin M., Edgington T.S. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26:851-858.
52. Ling H., Spizzo R., Atlasi Y., Nicoloso M., Shimizu M., Redis R.S., Nishida N., Gafa R., Song J., Guo Z., Ivan C., Barbarotto E., De Vries I., Zhang X., Ferracin M., Churchman M., van Galen J.F., Beverloo B.H., Shariati M., Haderk F., Estecio M.R., Garcia-Manero G., Patijn G.A., Gotley D.C., Bhardwaj V., Shureiqi I., Sen S., Multani A.S., Welsh J., Yamamoto K., Taniguchi I., Song M.A., Gallinger S., Casey G., Thibodeau S.N., Le Marchand L., Tiirikainen M., Mani S.A., Zhang W., Davuluri R.V., Mimori K., Mori M., Sieuwerts A.M., Martens J.W., Tomlinson I., Negrini M., Berindan-Neagoe I., Foekens J.A., Hamilton S.R., Lanza G., Kopetz S., Fodde R., Calin G.A. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013, 23:1446-1461.
53. Liu X.H., Liu Z.L., Sun M., Liu J., Wang Z.X., De W. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013, 13:464.
54. Liu X.H., Sun M., Nie F.Q., Ge Y.B., Zhang E.B., Yin D.D., Kong R., Xia R., Lu K.H., Li J.H., De W., Wang K.M., Wang Z.X. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol. Cancer 2014, 13:92.
55. Liu Y.N., Lee W.W., Wang C.Y., Chao T.H., Chen Y., Chen J.H. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 2005, 24:8277-8290.
56. Lottin S., Adriaenssens E., Dupressoir T., Berteaux N., Montpellier C., Coll J., Dugimont T., Curgy J.J. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 2002, 23:1885-1895.
57. Lu K.H., Li W., Liu X.H., Sun M., Zhang M.L., Wu W.Q., Xie W.P., Hou Y.Y. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 2013, 13:1471-2407.
58. Ma L., Bajic V.B., Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013, 10:925-933.
59. Malik R., Patel L., Prensner J.R., Shi Y., Iyer M.K., Subramaniyan S., Carley A., Niknafs Y.S., Sahu A., Han S., Ma T., Liu M., Asangani I.A., Jing X., Cao X., Dhanasekaran S.M., Robinson D.R., Feng F.Y., Chinnaiyan A.M. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol. Cancer Res. 2014, 12:1081-1087.
60. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
61. Matouk I.J., Abbasi I., Hochberg A., Galun E., Dweik H., Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur. J. Gastroenterol. Hepatol. 2009, 21:688-692.
62. Matouk I.J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A., Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007, 2:e845.
63. Matouk I.J., Mezan S., Mizrahi A., Ohana P., Abu-Lail R., Fellig Y., Degroot N., Galun E., Hochberg A. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta 2010, 1803:443-451.
64. Mehra R., Shi Y., Udager A.M., Prensner J.R., Sahu A., Iyer M.K., Siddiqui J., Cao X., Wei J., Jiang H., Feng F.Y., Chinnaiyan A.M. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia 2014, 16:1121-1127.
65. Meng W., Ye Z., Cui R., Perry J., Dedousi-Huebner V., Huebner A., Wang Y., Li B., Volinia S., Nakanishi H., Kim T., Suh S.S., Ayers L.W., Ross P., Croce C.M., Chakravarti A., Jin V.X., Lautenschlaeger T. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin. Cancer Res. 2013, 19:5423-5433.
66. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
67. Mercer T.R., Dinger M.E., Sunkin S.M., Mehler M.F., Mattick J.S. Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl. Acad. Sci. USA 2008, 105:716-721.
68. Mimeault M., Batra S.K. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis 2006, 27:1-22.
69. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28:195-208.
70. Nickerson T., Chang F., Lorimer D., Smeekens S.P., Sawyers C.L., Pollak M. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res. 2001, 61:6276-6280.
71. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., Nikaido I., Osato N., Saito R., Suzuki H., Yamanaka I., Kiyosawa H., Yagi K., Tomaru Y., Hasegawa Y., Nogami A., Schonbach C., Gojobori T., Baldarelli R., Hill D.P., Bult C., Hume D.A., Quackenbush J., Schriml L.M., Kanapin A., Matsuda H., Batalov S., Beisel K.W., Blake J.A., Bradt D., Brusic V., Chothia C., Corbani L.E., Cousins S., Dalla E., Dragani T.A., Fletcher C.F., Forrest A., Frazer K.S., Gaasterland T., Gariboldi M., Gissi C., Godzik A., Gough J., Grimmond S., Gustincich S., Hirokawa N., Jackson I.J., Jarvis E.D., Kanai A., Kawaji H., Kawasawa Y., Kedzierski R.M., King B.L., Konagaya A., Kurochkin I.V., Lee Y., Lenhard B., Lyons P.A., Maglott D.R., Maltais L., Marchionni L., McKenzie L., Miki H., Nagashima T., Numata K., Okido T., Pavan W.J., Pertea G., Pesole G., Petrovsky N., Pillai R., Pontius J.U., Qi D., Ramachandran S., Ravasi T., Reed J.C., Reed D.J., Reid J., Ring B.Z., Ringwald M., Sandelin A., Schneider C., Semple C.A., Setou M., Shimada K., Sultana R., Takenaka Y., Taylor M.S., Teasdale R.D., Tomita M., Verardo R., Wagner L., Wahlestedt C., Wang Y., Watanabe Y., Wells C., Wilming L.G., Wynshaw-Boris A., Yanagisawa M., Yang I., Yang L., Yuan Z., Zavolan M., Zhu Y., Zimmer A., Carninci P., Hayatsu N., Hirozane-Kishikawa T., Konno H., Nakamura M., Sakazume N., Sato K., Shiraki T., Waki K., Kawai J., Aizawa K., Arakawa T., Fukuda S., Hara A., Hashizume W., Imotani K., Ishii Y., Itoh M., Kagawa I., Miyazaki A., Sakai K., Sasaki D., Shibata K., Shinagawa A., Yasunishi A., Yoshino M., Waterston R., Lander E.S., Rogers J., Birney E., Hayashizaki Y. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 2002, 420:563-573.
72. Pandey R.R., Mondal T., Mohammad F., Enroth S., Redrup L., Komorowski J., Nagano T., Mancini-Dinardo D., Kanduri C. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 2008, 32:232-246.
73. Panzitt K., Tschernatsch M.M., Guelly C., Moustafa T., Stradner M., Strohmaier H.M., Buck C.R., Denk H., Schroeder R., Trauner M., Zatloukal K. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132:330-342.
74. Parolia A., Crea F., Xue H., Wang Y., Mo F., Ramnarine V.R., Liu H.H., Lin D., Saidy N.R., Clermont P.L., Cheng H., Collins C., Helgason C.D. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo. Mol. Cancer 2015, 14:46.
75. Pauli A., Valen E., Lin M.F., Garber M., Vastenhouw N.L., Levin J.Z., Fan L., Sandelin A., Rinn J.L., Regev A., Schier A.F. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res. 2012, 22:577-591.
76. Pinskaya M., Gourvennec S., Morillon A. H3 lysine 4 di- and tri-methylation deposited by cryptic transcription attenuates promoter activation. EMBO J. 2009, 28:1697-1707.
77. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
78. Prensner J.R., Chen W., Han S., Iyer M.K., Cao Q., Kothari V., Evans J.R., Knudsen K.E., Paulsen M.T., Ljungman M., Lawrence T.S., Chinnaiyan A.M., Feng F.Y. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia 2014, 16:900-908.
79. Prensner J.R., Chen W., Iyer M.K., Cao Q., Ma T., Han S., Sahu A., Malik R., Wilder-Romans K., Navone N., Logothetis C.J., Araujo J.C., Pisters L.L., Tewari A.K., Canman C.E., Knudsen K.E., Kitabayashi N., Rubin M.A., Demichelis F., Lawrence T.S., Chinnaiyan A.M., Feng F.Y. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res. 2014, 74:1651-1660.
80. Prensner J.R., Sahu A., Iyer M.K., Malik R., Chandler B., Asangani I.A., Poliakov A., Vergara I.A., Alshalalfa M., Jenkins R.B., Davicioni E., Feng F.Y., Chinnaiyan A.M. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget 2014, 5:1434-1438.
81. Qin R., Chen Z., Ding Y., Hao J., Hu J., Guo F. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma 2013, 60:486-492.
82. Qiu M., Xu Y., Yang X., Wang J., Hu J., Xu L., Yin R. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol. 2014, 35:5375-5380.
83. Redis R.S., Sieuwerts A.M., Look M.P., Tudoran O., Ivan C., Spizzo R., Zhang X., de Weerd V., Shimizu M., Ling H., Buiga R., Pop V., Irimie A., Fodde R., Bedrosian I., Martens J.W., Foekens J.A., Berindan-Neagoe I., Calin G.A. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget 2013, 4:1748-1762.
84. Ren S., Liu Y., Xu W., Sun Y., Lu J., Wang F., Wei M., Shen J., Hou J., Gao X., Xu C., Huang J., Zhao Y. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J. Urol. 2013, 190:2278-2287.
85. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Varambally R., Yu J., Briggs B.B., Barrette T.R., Anstet M.J., Kincead-Beal C., Kulkarni P., Varambally S., Ghosh D., Chinnaiyan A.M. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9:166-180.
86. Ricke W.A., McPherson S.J., Bianco J.J., Cunha G.R., Wang Y., Risbridger G.P. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J. 2008, 22:1512-1520.
87. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
88. Sakurai K., Reon B.J., Anaya J., Dutta A. The lncRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive nexus. Mol. Cancer Res. 2015, 13:828-838.
89. Salvador M.A., Wicinski J., Cabaud O., Toiron Y., Finetti P., Josselin E., Lelievre H., Kraus-Berthier L., Depil S., Bertucci F., Collette Y., Birnbaum D., Charafe-Jauffret E., Ginestier C. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin. Cancer Res. 2013, 19:6520-6531.
90. Schmidt L.H., Spieker T., Koschmieder S., Schaffers S., Humberg J., Jungen D., Bulk E., Hascher A., Wittmer D., Marra A., Hillejan L., Wiebe K., Berdel W.E., Wiewrodt R., Muller-Tidow C. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J. Thorac. Oncol. 2011, 6:1984-1992.
91. Shi X., Sun M., Liu H., Yao Y., Kong R., Chen F., Song Y. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol. Carcinog. 2013, 1(54 Suppl):E1-E12.
92. Singh D., Febbo P.G., Ross K., Jackson D.G., Manola J., Ladd C., Tamayo P., Renshaw A.A., D'Amico A.V., Richie J.P., Lander E.S., Loda M., Kantoff P.W., Golub T.R., Sellers W.R. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002, 1:203-209.
93. Song H., Sun W., Ye G., Ding X., Liu Z., Zhang S., Xia T., Xiao B., Xi Y., Guo J. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J. Transl Med. 2013, 11:225.
94. Spitale R.C., Tsai M.C., Chang H.Y. RNA templating the epigenome: long noncoding RNAs as molecular scaffolds. Epigenetics 2011, 6:539-543.
95. Srikantan V., Zou Z., Petrovics G., Xu L., Augustus M., Davis L., Livezey J.R., Connell T., Sesterhenn I.A., Yoshino K., Buzard G.S., Mostofi F.K., McLeod D.G., Moul J.W., Srivastava S. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA 2000, 97:12216-12221.
96. Starkova J., Zamostna B., Mejstrikova E., Krejci R., Drabkin H.A., Trka J. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL. Pediatr. Blood Cancer 2010, 55:1072-1082.
97. Sun M., Liu X.H., Wang K.M., Nie F.Q., Kong R., Yang J.S., Xia R., Xu T.P., Jin F.Y., Liu Z.J., Chen J.F., Zhang E.B., De W., Wang Z.X. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol. Cancer 2014, 13:68.
98. Tano K., Mizuno R., Okada T., Rakwal R., Shibato J., Masuo Y., Ijiri K., Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010, 584:4575-4580.
99. Taylor B.S., Schultz N., Hieronymus H., Gopalan A., Xiao Y., Carver B.S., Arora V.K., Kaushik P., Cerami E., Reva B., Antipin Y., Mitsiades N., Landers T., Dolgalev I., Major J.E., Wilson M., Socci N.D., Lash A.E., Heguy A., Eastham J.A., Scher H.I., Reuter V.E., Scardino P.T., Sander C., Sawyers C.L., Gerald W.L. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18:11-22.
100. Thorvaldsen J.L., Fedoriw A.M., Nguyen S., Bartolomei M.S. Developmental profile of H19 differentially methylated domain (DMD) deletion alleles reveals multiple roles of the DMD in regulating allelic expression and DNA methylation at the imprinted H19/Igf2 locus. Mol. Cell Biol. 2006, 26:1245-1258.
101. van Werven F.J., Neuert G., Hendrick N., Lardenois A., Buratowski S., van Oudenaarden A., Primig M., Amon A. Transcription of two long noncoding RNAs mediates mating-type control of gametogenesis in budding yeast. Cell 2012, 150:1170-1181.
102. Wang D., Garcia-Bassets I., Benner C., Li W., Su X., Zhou Y., Qiu J., Liu W., Kaikkonen M.U., Ohgi K.A., Glass C.K., Rosenfeld M.G., Fu X.D. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474:390-394.
103. Weber D.G., Johnen G., Casjens S., Bryk O., Pesch B., Jockel K.H., Kollmeier J., Bruning T. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res. Notes 2013, 6:518.
104. Weksberg R., Nishikawa J., Caluseriu O., Fei Y.L., Shuman C., Wei C., Steele L., Cameron J., Smith A., Ambus I., Li M., Ray P.N., Sadowski P., Squire J. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum. Mol. Genet. 2001, 10:2989-3000.
105. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., Frierson H.F., Hampton G.M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001, 61:5974-5978.
106. Wendt M.K., Taylor M.A., Schiemann B.J., Schiemann W.P. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol. Biol. Cell. 2011, 22:2423-2435.
107. Xu Z.Y., Yu Q.M., Du Y.A., Yang L.T., Dong R.Z., Huang L., Yu P.F., Cheng X.D. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int. J. Biol. Sci. 2013, 9:587-597.
108. Yang F., Bi J., Xue X., Zheng L., Zhi K., Hua J., Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012, 279:3159-3165.
109. Yang L., Lin C., Jin C., Yang J.C., Tanasa B., Li W., Merkurjev D., Ohgi K.A., Meng D., Zhang J., Evans C.P., Rosenfeld M.G. LncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 2013, 500:598-602.
110. Ylipaa A., Kivinummi K., Kohvakka A., Annala M., Latonen L., Scaravilli M., Kartasalo K., Leppanen S.P., Karakurt S., Seppala J., Yli-Harja O., Tammela T.L., Zhang W., Visakorpi T., Nykter M. Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long noncoding RNA in prostate cancer. Cancer Res. 2015, 75:4026-4031.
111. Yu J., Mani R.S., Cao Q., Brenner C.J., Cao X., Wang X., Wu L., Li J., Hu M., Gong Y., Cheng H., Laxman B., Vellaichamy A., Shankar S., Li Y., Dhanasekaran S.M., Morey R., Barrette T., Lonigro R.J., Tomlins S.A., Varambally S., Qin Z.S., Chinnaiyan A.M. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell. 2010, 17:443-454.
112. Zhao J., Sun B.K., Erwin J.A., Song J.J., Lee J.T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008, 322:750-756.
113. Zhou Y., Zhang X., Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J. Mol. Endocrinol. 2012, 48:R45-R53.